These findings provide a better understanding of the pathogenesis, progression, and metastasis of HNSCC, and suggest that lncRNA MASCC1 has potential value as a therapeutic target in patients with HNSCC. The gene discussed is VHRT; the disease is head and neck squamous cell carcinoma.